Stock Information
Eikon Therapeutics Inc (EIKN)
Ticker Symbol: EIKN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $393.05 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -10.10
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -119.66%
Latest News
-
Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress
Sun, Oct 18, 2026 10:05 PM
-
HC Wainwright & Co. Initiates Coverage On Eikon Therapeutics with Buy Rating, Announces Price Target of $23
Fri, Oct 16, 2026 6:11 AM
-
Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer
Thu, Oct 15, 2026 12:00 PM
-
Eikon Therapeutics Files Submits Investigational New Drug Application To FDA To Evaluate EIK1006 To Treat Advanced Metastatic Prostate Cancer
Thu, Oct 15, 2026 8:06 AM
Key Financials
Financial data not available
